RU-301 is primarily used in research settings for its potential neuroprotective properties. It has shown activity in preclinical models related to ischemic brain injury, where it may help reduce neuronal damage following stroke-like conditions. The compound is investigated for its ability to modulate cellular signaling pathways involved in apoptosis and inflammation, making it a candidate for studying therapeutic interventions in neurodegenerative diseases. Due to its experimental status, RU-301 is not used clinically but serves as a tool compound in neuroscience research to explore mechanisms of brain cell survival and injury response.